NCT07833748 Integrated Motor-Cognitive Training in Parkinson's Disease: A Feasibility Study
| NCT ID | NCT07833748 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | PARKINSON DISEASE (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2026-06-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's disease is a progressive neurodegenerative condition characterized by both motor symptoms (such as bradykinesia, rigidity, tremor, and postural instability) and non-motor symptoms, including cognitive impairments (affecting working memory, executive functions, and attention). Combined interventions that target both domains simultaneously or consecutively have shown potential to produce superior benefits compared to isolated motor or cognitive training. The purpose of this study is to evaluate the feasibility, adherence, and preliminary clinical results of efficacy of an integrated and combined motor-cognitive rehabilitation training in patients diagnosed with Parkinson's disease. This feasibility study will enroll 12 participants with Parkinson's disease. All participants will undergo a comprehensive 10-session integrated rehabilitation program combining digital cognitive individual stimulation and group functional motor training. The primary focus is to assess acceptability, safety, and adherence to this combined approach, while secondary outcomes will observe changes in relevant cognitive and motor clinical variables.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Parkinson's disease * Presence of motor symptoms attributable to Parkinson's disease * Availability to participate in both treatments (cognitive and motor) * Severity of symptoms compatible with participation in group physical therapy * Absence of other medical conditions that could interfere with treatment delivery * Montreal Cognitive Assessment (MoCA) score \>= 18 * Consent to participate in group-based motor training * Absence of falls in the 3 months prior to baseline evaluation Exclusion Criteria: * Concomitant major neurological or psychiatric disorders * Severe cardio-pulmonary, renal, or hepatic diseases * Changes in baseline pharmacological therapy within 3 months prior to enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07833748 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PARKINSON DISEASE (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07833748 currently recruiting?
Yes, NCT07833748 is actively recruiting participants. Contact the research team at sofia.straudi@unife.it for enrollment information.
Where is the NCT07833748 trial being conducted?
This trial is being conducted at Ferrara, Italy.
Who is sponsoring the NCT07833748 clinical trial?
NCT07833748 is sponsored by University Hospital of Ferrara. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.